Beauty Health [SKIN] vs Procter & Gamble [PG] Detailed Stock Comparison

Beauty Health
NASDAQ
Loading...

Procter & Gamble
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Beauty Health wins in 8 metrics, Procter & Gamble wins in 10 metrics, with 0 ties. Procter & Gamble appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | Beauty Health | Procter & Gamble | Better |
---|---|---|---|
P/E Ratio (TTM) | -8.91 | 24.54 | Beauty Health |
Price-to-Book Ratio | 3.51 | 7.30 | Beauty Health |
Debt-to-Equity Ratio | 509.08 | 69.86 | Procter & Gamble |
PEG Ratio | 0.00 | 21.53 | Beauty Health |
EV/EBITDA | -27.15 | 16.39 | Beauty Health |
Profit Margin (TTM) | -6.13% | 18.95% | Procter & Gamble |
Operating Margin (TTM) | -3.45% | 25.15% | Procter & Gamble |
EBITDA Margin (TTM) | N/A | 25.15% | N/A |
Return on Equity | -26.55% | 31.24% | Procter & Gamble |
Return on Assets (TTM) | -4.45% | 10.91% | Procter & Gamble |
Free Cash Flow (TTM) | $9.34M | $14.04B | Procter & Gamble |
Dividend Yield | N/A | 1.92% | N/A |
1-Year Return | 45.39% | -8.87% | Beauty Health |
Price-to-Sales Ratio (TTM) | 0.84 | 4.44 | Beauty Health |
Enterprise Value | $426.72M | $400.90B | Procter & Gamble |
EV/Revenue Ratio | 1.38 | 4.76 | Beauty Health |
Gross Profit Margin (TTM) | 62.81% | 49.11% | Beauty Health |
Revenue per Share (TTM) | $2 | $36 | Procter & Gamble |
Earnings per Share (Diluted) | $-0.18 | $6.51 | Procter & Gamble |
Beta (Stock Volatility) | 1.23 | 0.36 | Procter & Gamble |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Beauty Health vs Procter & Gamble Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
Beauty Health | 1.99% | -1.44% | 24.24% | 28.13% | 58.91% | 27.33% |
Procter & Gamble | 0.52% | 1.90% | 6.32% | -1.71% | -8.36% | -3.59% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
Beauty Health | 45.39% | -83.67% | -79.92% | -79.92% | -79.92% | -79.92% |
Procter & Gamble | -8.87% | 14.33% | 15.84% | 133.88% | 164.93% | 181.23% |
Performance & Financial Health Analysis: Beauty Health vs Procter & Gamble
Metric | SKIN | PG |
---|---|---|
Market Information | ||
Market Cap | $259.99M | $374.83B |
Market Cap Category | Small cap | Mega cap |
10 Day Avg. Volume | 710,960 | 5,263,346 |
90 Day Avg. Volume | 1,146,780 | 6,819,689 |
Last Close | $2.05 | $160.02 |
52 Week Range | $0.78 - $2.56 | $149.91 - $180.43 |
% from 52W High | -19.92% | -11.31% |
All-Time High | $30.17 (Nov 01, 2021) | $180.43 (Nov 25, 2024) |
% from All-Time High | -93.21% | -11.31% |
Growth Metrics | ||
Quarterly Revenue Growth | -0.14% | 0.02% |
Quarterly Earnings Growth | 96.58% | 0.15% |
Financial Health | ||
Profit Margin (TTM) | -0.06% | 0.19% |
Operating Margin (TTM) | -0.03% | 0.25% |
Return on Equity (TTM) | -0.27% | 0.31% |
Debt to Equity (MRQ) | 509.08 | 69.86 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | $0.58 | $21.88 |
Cash per Share (MRQ) | $1.66 | $4.08 |
Operating Cash Flow (TTM) | $39.43M | $17.82B |
Levered Free Cash Flow (TTM) | $40.34M | $11.38B |
Dividends | ||
Last 12-Month Dividend Yield | N/A | 1.92% |
Last 12-Month Dividend | N/A | $3.03 |
Valuation & Enterprise Metrics Analysis: Beauty Health vs Procter & Gamble
Metric | SKIN | PG |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | -8.91 | 24.54 |
Forward P/E | -12.81 | 21.53 |
PEG Ratio | 0.00 | 21.53 |
Price to Sales (TTM) | 0.84 | 4.44 |
Price to Book (MRQ) | 3.51 | 7.30 |
Market Capitalization | ||
Market Capitalization | $259.99M | $374.83B |
Enterprise Value | $426.72M | $400.90B |
Enterprise Value Metrics | ||
Enterprise to Revenue | 1.38 | 4.76 |
Enterprise to EBITDA | -27.15 | 16.39 |
Risk & Other Metrics | ||
Beta | 1.23 | 0.36 |
Book Value per Share (MRQ) | $0.58 | $21.88 |
Financial Statements Comparison: Beauty Health vs Procter & Gamble
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | SKIN | PG |
---|---|---|
Revenue/Sales | $78.19M | $20.89B |
Cost of Goods Sold | $29.08M | $10.63B |
Gross Profit | $49.11M | $10.26B |
Research & Development | $1.25M | N/A |
Operating Income (EBIT) | $-2.70M | $4.35B |
EBITDA | $24.01M | $5.46B |
Pre-Tax Income | $18.72M | $4.52B |
Income Tax | $-993,000 | $895.00M |
Net Income (Profit) | $19.71M | $3.63B |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | SKIN | PG |
---|---|---|
Cash & Equivalents | $373.03M | $9.56B |
Total Current Assets | $469.37M | $25.39B |
Total Current Liabilities | $62.80M | $36.06B |
Long-Term Debt | $562.61M | $25.70B |
Total Shareholders Equity | $46.06M | $52.28B |
Retained Earnings | $-518.06M | $129.97B |
Property, Plant & Equipment | $13.21M | $0 |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | SKIN | PG |
---|---|---|
Operating Cash Flow | $-577,000 | $3.71B |
Capital Expenditures | $-45,000 | N/A |
Free Cash Flow | $1.85M | $2.85B |
Debt Repayment | $0 | $-1.05B |
Common Stock Repurchase | N/A | $-1.35B |
Short Interest & Institutional Ownership Analysis
Metric | SKIN | PG |
---|---|---|
Shares Short | 15.47M | 16.72M |
Short Ratio | 11.39 | 2.21 |
Short % of Float | 0.27% | 0.01% |
Average Daily Volume (10 Day) | 710,960 | 5,263,346 |
Average Daily Volume (90 Day) | 1,146,780 | 6,819,689 |
Shares Outstanding | 124.92M | 2.34B |
Float Shares | 81.55M | 2.34B |
% Held by Insiders | 0.10% | 0.00% |
% Held by Institutions | 0.86% | 0.70% |
Dividend Analysis & Yield Comparison: Beauty Health vs Procter & Gamble
Metric | SKIN | PG |
---|---|---|
Last 12-Month Dividend | N/A | $3.03 |
Last 12-Month Dividend Yield | N/A | 1.92% |
3-Year Avg Annual Dividend | N/A | $3.51 |
3-Year Avg Dividend Yield | N/A | 0.63% |
3-Year Total Dividends | N/A | $10.53 |
Ex-Dividend Date | N/A | Jan 24, 2025 |